About PCL Diagnostics
PCL Diagnostics was founded in 2008 in Seoul, South Korea, within the biotechnology sector. Biochips are produced for diagnostic applications, leveraging SG Cap technology to immobilize macromolecules such as proteins, nucleic acids, and aptamers. SolB chips enable multiplex detection of infectious diseases, respiratory viruses, and cancer markers. Automated analysis is facilitated by the SolB Desktop Arrayer instrument. Operations focus on advancing diagnostic tools for clinical use.
- Headquarter Seoul, South Korea
- Stage Public
- SectorsHealthcare
- Website pclchip.com
Web traffic of PCL Diagnostics
The website of PCL Diagnostics (pclchip.com) receives about 5.4K visits a month.
- Monthly visits5.4K
▲ 21.6% vs previous month
Websites whose visitors overlap most with PCL Diagnostics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| healthinnews.co.kr | 100% | – | – | View details | |
dailymedi.com | dailymedi.com | 74% | – | #145,758 | – |
bosa.co.kr | bosa.co.kr | 60% | – | #127,846 | – |
docdocdoc.co.kr | docdocdoc.co.kr | 60% | – | #141,726 | – |
dailypharm.com | dailypharm.com | 60% | – | #33,384 | – |
Latest news on Pcl Diagnostics
Complete news archive for PCL Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to PCL Diagnostics
10 companies that operate in the same segment as PCL Diagnostics (Diagnostics & Lab Tech), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceuticals and diagnostics kits are developed for various diseases. | 1896 | Basel, Basel-stadt, Switzerland | – | USD 77.61 B | 103,250 | |
Point-of-care and laboratory blood analyzers are developed by EKF. | 1990 | Penarth, Wales, United Kingdom | USD 178.63 K | USD 69.43 M | 303 | |
Blood testing services are offered using finger-prick microsamples. | 2017 | Austin, Texas, United States | USD 37.7 M | – | – | |
Manufactures clinical diagnostic test kits | 1971 | Irvine, California, United States | – | USD 4.45 M | 54 | |
Biomarker-based diagnostic solutions for cancer and cardiovascular diseases are developed. | 2002 | Hennigsdorf, Brandenburg, Germany | USD 36.14 M | – | – | |
Diagnostic instrumentation and assays | 1987 | Puteaux, Hauts-de-seine, France | – | – | – | |
Manufacturer of Laboratory equipment | 1955 | Norwood, Massachusetts, United States | – | – | – | |
Cloud based diagnostics platform for point of care diagnosing | 2014 | Waltham, Massachusetts, United States | USD 703.91 M | USD 115.02 K | 9 | |
Diagnostics technology for infectious diseases and health monitoring is provided. | 2012 | Hong Kong, China | USD 34 M | – | – | |
Global leader for In Vitro Diagnostic | 1959 | Barcelona, Catalonia, Spain | – | USD 61.01 M | 346 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about PCL Diagnostics
PCL Diagnostics was founded in 2008.
PCL Diagnostics is headquartered in Seoul, South Korea.
PCL Diagnostics was founded in 2008 in Seoul, South Korea, within the biotechnology sector. Biochips are produced for diagnostic applications, leveraging SG Cap technology to immobilize macromolecules such as proteins, nucleic acids, and aptamers. SolB chips enable multiplex detection of infectious diseases, respiratory viruses, and cancer markers. Automated analysis is facilitated by the SolB Desktop Arrayer instrument. Operations focus on advancing diagnostic tools for clinical use.